Imaging-Guided Vessel Sizing in the Tibial Arteries
Key facts
- Who runs it
- University Hospitals Cleveland Medical Center
- Where
- Beachwood, Cleveland, and Parma, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 16 Aug 2021
- Ended
- 9 Jun 2024
- Type of study
- Observational
- Treatments tested
- Digital Subtraction Angiography
- Record updated
- 2 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (5)Hide the full registry criteria
Who can take part
- Age >18
- Patients with presence of Rutherford IV-VI
- Presence of ≥1 tibial artery involvement requiring endovascular treatment
Who cannot take part
- Patients who do not have tibial disease appropriate for intervention
- Estimated glomerular filtration rate <30 mL/min not on hemodialysis
Where in United States
- University Hospitals Ahuja Medical CenterBeachwood, United States
- University Hospitals Cleveland Medical Center*Cleveland, United States
- University Hospitals Parma Medical CenterParma, United States
About the trial
What the trial wants to find out
This study aims to investigate the utilization of intravascular imaging in treatment of tibial vessels in peripheral artery disease and critical limb ischemia (CLI). The primary goal is to compare optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. Secondary comparison with intravascular ultrasound (IVUS) is undertaken when clinically feasible. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.
The group in the trial
- Tibial Vessel Involvement in Patients with peripheral artery disease and CLI
The primary goal is to establish a protocol for performing optimal OCT in below-the-knee vessels. OCT images will be analyzed for lesion characteristics, lesion sizing pre- and post-intervention. This will be analyzed against QVA and IVUS (latter if applicable).
Treatment: Digital Subtraction Angiography
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 2 May 2025